Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8999804 | 1.00 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2976999 | 1.00 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2964958 | 1.00 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL368248 | 1.00 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2971445 | 1.00 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2979522 | 1.00 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2945488 | 0.98 | CYP1A2 (0.49) | CYP1A2EPHX1 | |
| SCHEMBL25200172 | 0.95 | CYP1A2 (0.46) | CYP1A2EPHX1 | |
| SCHEMBL486920 | 0.95 | CYP1A2 (0.46) | CYP1A2EPHX1 | |
| SCHEMBL28396829 | 0.95 | CYP1A2 (0.46) | CYP1A2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773284-B1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THEIR USE IN PERFUMERY | MANE FILS V (FR) | 2010-09-15 | — | — | EP | claimed |
| EP-1773284-A1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THE USE THEREOF | V. Mane Fils (FR) | 2007-04-18 | — | — | EP | claimed |
| WO-2006021663-A1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THE USE THEREOF | V. MANE FILS (FR) | 2006-03-02 | — | — | WO | claimed |
| US-12018226-B2 | Perfuming compositions | FIRMENICH SA (CH) | 2024-06-25 | — | — | US | disclosed |
| US-20200325415-A1 | PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2020-10-15 | — | — | US | disclosed |
| US-20190264133-A1 | PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2019-08-29 | — | — | US | disclosed |
| CN-109689848-A | Spice composition | 奇华顿股份有限公司 | 2019-04-26 | — | — | CN | disclosed |
| US-8853426-B2 | Method for manufacturing ester | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20130217898-A1 | METHOD FOR MANUFACTURING ESTER | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-08-22 | — | — | US | disclosed |
| EP-1773284-B1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THEIR USE IN PERFUMERY | MANE FILS V (FR) | 2010-09-15 | — | — | EP | disclosed |
| EP-1773284-A1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THE USE THEREOF | V. Mane Fils (FR) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006021663-A1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THE USE THEREOF | V. MANE FILS (FR) | 2006-03-02 | — | — | WO | disclosed |
| EP-0341773-B1 | Process for the preparation of lactones | SHELL INT RESEARCH (NL) | 1996-09-11 | — | — | EP | disclosed |
| EP-0341773-A1 | Process for the preparation of lactones | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217898-A1 | METHOD FOR MANUFACTURING ESTER | CBR3, BCKDK, ACSL4 | CYP1A2 585/4885EPHX1 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.